Back to Medicines

Cabotegravir: Long-Acting Injectable HIV Treatment

Cabotegravir: Long-Acting Injectable HIV Treatment
Prescription Medicines Editorial 6 January 2026

Cabotegravir is an integrase inhibitor formulated as a long-acting injection. Given with rilpivirine every one or two months, it replaces daily tablets for HIV treatment. Given alone, it is injectable pre-exposure prophylaxis. For people who find daily tablets difficult, or for whom keeping medication at home creates a privacy problem, it removes the daily decision entirely. The trade-off is that the drug clears very slowly afterwards, and that slow tail is where the risk sits.

Follow the plan your HIV team gave you. This guide contains no doses.

How it works in practice

Treatment usually begins with an oral lead-in period to check tolerance, then moves to injections given into the buttock muscle - initially a loading dose, then at regular intervals.

Appointments become the treatment. There is nothing to take between them, and nothing to forget except the date.

For prevention, cabotegravir alone is given at longer intervals and has performed extremely well in trials - better than daily oral PrEP, largely because adherence to an injection every couple of months is easier than adherence to a tablet every day.

Our guide to emtricitabine and tenofovir covers oral PrEP.

The pharmacokinetic tail

This is the part that needs understanding. After the last injection, cabotegravir remains detectable in the body for months - at gradually falling concentrations.

Falling concentrations are exactly the conditions under which resistant virus is selected. So if injections stop without cover, the tail becomes a long period of sub-therapeutic drug exposure.

Consequences:

  • If you stop, oral treatment must be started to cover the tail. This is planned, not improvised.
  • Missing an appointment matters more than missing a tablet. There are windows either side, and oral bridging is used if a gap is unavoidable - but the clinic needs to know in advance.
  • For PrEP, testing continues during the tail, since acquiring HIV while low levels of a single drug are present risks resistance.

If you know you will miss an appointment, ring the clinic before the date rather than after. They plan around this routinely.

Who it suits

People with a suppressed viral load already, no history of resistance to the components, and no hepatitis B - since cabotegravir and rilpivirine do not treat hepatitis B, and someone whose hepatitis was being suppressed by their previous tablets would flare. See lamivudine.

It requires being able to attend reliably. That is a genuine consideration rather than a formality, and it is worth being honest about your circumstances when it is offered.

A high BMI can affect absorption from the injection site, which is taken into account.

Injection site reactions

Pain, tenderness, a lump, swelling or warmth at the site are very common - affecting most people after the first injections - and usually settle within a few days.

They tend to become less troublesome over time. Moving around afterwards, and a warm compress, help.

Report a site reaction that is spreading, increasingly painful, or accompanied by fever.

Other side effects

Headache, fever, fatigue, muscle aches and nausea in the days after an injection, particularly early on.

Sleep disturbance, vivid dreams and mood changes are reported with integrase inhibitors - worth raising rather than enduring. Weight gain is recognised with the class - see bictegravir.

Seek urgent advice for rash with fever, or jaundice with dark urine and abdominal pain - hypersensitivity and liver reactions are rare but recognised.

Interactions

Enzyme inducers substantially reduce cabotegravir levels and are contraindicated - rifampicin and rifabutin, carbamazepine, phenytoin, and St John's wort.

That matters particularly for anyone who might need tuberculosis treatment, where the interaction forces a switch away from injections. See carbamazepine and supplements that interfere with your medicines.

Unlike the oral integrase inhibitors, the injection is not affected by antacids and supplements - there is no absorption step to interfere with, which is a real practical advantage.

Tell every prescriber you are on injectable HIV treatment, because they will not see a tablet on your repeat list.

Before you start

The oral lead-in exists so that if you react badly to either drug, it can be stopped quickly - which is not possible once an injection has been given.

It is worth taking that period seriously and reporting anything troublesome during it rather than pressing on, because the injection commits you to weeks of exposure. Some clinics now omit the lead-in for people already established on similar drugs, which is a reasonable discussion to have.

Undetectable equals untransmittable

A sustained undetectable viral load means HIV cannot be passed on sexually. That holds on injectable treatment as on tablets, provided the schedule is kept - see dolutegravir.

Viral load monitoring continues throughout, which is how the clinic confirms it is working.

HIV treatment, PrEP and testing are free in the UK regardless of immigration status.

The Medicines section covers more on how the main families of medicine work - Sodium Fluoride: High-Fluoride Toothpaste on Prescription is closely related to this one.